Evidence map›Paper›PMID 35711435›Full record

ArticleFrontiers in immunology2022

Differential Functional Responses of Neutrophil Subsets in Severe COVID-19 Patients.

Kenneth R McLeish, Rejeena Shrestha, Aruna Vashishta, Madhavi J Rane, Michelle T Barati, Michael E Brier, Mario Gutierrez Lau, Xiaoling Hu, Oscar Chen, Caitlin R Wessel and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Neutrophil Killing ofJournal of innate immunity · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Locally organised and activated Fth1Nature communications · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Kenneth R McLeishDivision of Nephrology and Hypertension, Department of Medicine, University of Louisville, KY, United States.
Rejeena ShresthaDepartment of Microbiology and Immunology, University of Louisville, KY, United States.
Aruna VashishtaDepartment of Oral Immunology and Infectious Diseases, School of Dentistry, University of Louisville, KY, United States.
Madhavi J RaneDivision of Nephrology and Hypertension, Department of Medicine, University of Louisville, KY, United States.
Michelle T BaratiDivision of Nephrology and Hypertension, Department of Medicine, University of Louisville, KY, United States.
Michael E BrierDivision of Nephrology and Hypertension, Department of Medicine, University of Louisville, KY, United States.
Mario Gutierrez LauDepartment of Oral Immunology and Infectious Diseases, School of Dentistry, University of Louisville, KY, United States.
Xiaoling HuDivision of Immunotherapy, The Hiram C. Polk, Jr., MD Department of Surgery, Immuno-Oncology Program, Brown Cancer Center, University of Louisville, Louisville, KY, United States.
Oscar ChenDepartment of Anesthesiology and Perioperative Medicine, University of Louisville, KY, United States.
Caitlin R WesselDepartment of Anesthesiology and Perioperative Medicine, University of Louisville, KY, United States.
Travis SpaldingDepartment of Anesthesiology and Perioperative Medicine, University of Louisville, KY, United States.
Sarah E BushDepartment of Anesthesiology and Perioperative Medicine, University of Louisville, KY, United States.
Kenechi IjemereDepartment of Anesthesiology and Perioperative Medicine, University of Louisville, KY, United States.
C Danielle HopkinsDepartment of Anesthesiology and Perioperative Medicine, University of Louisville, KY, United States.
Elizabeth A CookeDepartment of Anesthesiology and Perioperative Medicine, University of Louisville, KY, United States.
Shweta TandonDivision of Nephrology and Hypertension, Department of Medicine, University of Louisville, KY, United States.
Terri ManningDivision of Nephrology and Hypertension, Department of Medicine, University of Louisville, KY, United States.
Silvia M UriarteDepartment of Oral Immunology and Infectious Diseases, School of Dentistry, University of Louisville, KY, United States.
Jiapeng HuangDepartment of Anesthesiology and Perioperative Medicine, University of Louisville, KY, United States.
Jun YanDepartment of Microbiology and Immunology, University of Louisville, KY, United States.
University of Louisville · US

Funding

University of Louisville Center for Integrative Environmental Health SciencesP30ES030283 · NIEHS · UNIVERSITY OF LOUISVILLE · PI Amanda Jo LeBlanc · 2020 to 2026
$10.0M
A Handheld Microchip for GC analysis of breath to screen for COVID-19U18TR003787 · NCATS · UNIVERSITY OF LOUISVILLE · PI FU, XIAO-AN, NANTZ, MICHAEL H · 2021 to 2022
$2.0M
NCATS NIH HHS U18 TR003787NIEHS NIH HHS P30 ES030283
6 · The paper itself

Abstract

Neutrophils play a significant role in determining disease severity following SARS-CoV-2 infection. Gene and protein expression defines several neutrophil clusters in COVID-19, including the emergence of low density neutrophils (LDN) that are associated with severe disease. The functional capabilities of these neutrophil clusters and correlation with gene and protein expression are unknown. To define host defense and immunosuppressive functions of normal density neutrophils (NDN) and LDN from COVID-19 patients, we recruited 64 patients with severe COVID-19 and 26 healthy donors (HD). Phagocytosis, respiratory burst activity, degranulation, neutrophil extracellular trap (NET) formation, and T-cell suppression in those neutrophil subsets were measured. NDN from severe/critical COVID-19 patients showed evidence of priming with enhanced phagocytosis, respiratory burst activity, and degranulation of secretory vesicles and gelatinase and specific granules, while NET formation was similar to HD NDN. COVID LDN response was impaired except for enhanced NET formation. A subset of COVID LDN with intermediate CD16 expression (CD16

Indexed as

COVID-19Extracellular TrapsHumansNeutrophilsRespiratory BurstSARS-CoV-2COVID-19exocytosislow density neutrophilNET formationneutrophilrespiratory burstT cell proliferation

Identifiers

PMID35711435
PMCPMC9197482
OpenAlexW4281921977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.